lyj19721101 2015-07-16 15:12 IP:马鞍山
罕见癌症研究基金会(RCRF),致力于通过战略投资和创新合作进行基础治疗罕见的癌症,和美国文化募捐组织(ATCC),世界上最大的非营利性细胞株库,建立神经内分泌肿瘤细胞株收集目录。肠道良性肿瘤和胰腺神经内分泌肿瘤(PNET)需求一种新疗法的研究和发展,即在体内原发性肿瘤中建立新的细胞株。 为了刺激发展新的良性肿瘤和PNET细胞系,该基金会是高兴地宣布第二次开放竞争十个人奖项:开发人员的第一个新的细胞系在每个疾病(肠道良性肿瘤和PNET)将获得100000美元,开发者的第二,第三,第四,第五个新细胞系在每个疾病将会收到50000美元。原文如下:https://www.innocentive.com/ar/challenge/9933756 The lack of well-validated and widely accepted cell lines derived from intestinal carcinoid and pancreatic neuroendocrine tumors (PNET) is a significant barrier for research and development of new therapies. The Caring for Carcinoid Foundation therefore wishes to launch a second Challenge to stimulate a concerted effort to create a “collection” of well-characterized cell lines that faithfully replicate tumor characteristics and genetics. The Foundation has partnered with the Rare Cancer Research Foundation (RCRF), a foundation dedicated to curing rare cancers through strategic investments and innovative collaborations, and the American Type Culture Collection (ATCC), the world’s largest non-profit cell line repository, to establish a Neuroendocrine Tumor Cell Line collection in their catalog. This is a Reduction-to-Practice Challenge that requires written documentation, detailed description of each cell line, and sample delivery. Source: InnoCentive Challenge ID: 9933756 Challenge Overview This Challenge is intended to encourage innovative approaches to establishing new cell lines from primary tumors that grow slowly in vivo and to publicize new methods as well as availability of the new cell lines for broad, unrestricted use. To stimulate development of new carcinoid and PNET cell lines, the Foundation is pleased to announce its second open competition for up to ten individual prizes: Developers of the first new cell lines in each disease (intestinal carcinoid and PNET) will receive $100,000 each and developers of the second, third, fourth, and fifth new cell lines in each disease will receive $50,000 each. Individual   [更多]
悬赏:
悬赏
¥600000.00
载入中...
xiaomaguohe 2020-07-17 14:07 IP:济南
因业务需要,拟求购盐酸溴己新大生产工艺,也可协商合作生产。 提供有效联系方式可获得赏金   [更多]
悬赏:
悬赏
¥50000.00
载入中...
tommorow 2016-07-17 15:15 IP:临沂
专利申请号:201620283879.X,实用新型,处于授权未交费状态。   [更多]
悬赏:
悬赏
¥3750000.00
载入中...
zgdwlfzcy 2021-09-19 14:51 IP:XX
成熟可靠技术独特环境友好   [更多]
悬赏:
悬赏
¥2000.00
载入中...
njzc1234 2019-11-07 15:58 IP:南京
盐酸纳呋拉啡或盐酸纳呋拉啡口崩片的信息。   [更多]
悬赏:
悬赏
¥1600.00
载入中...
Jinghan 2021-08-20 14:01 IP:上海
大家好!我们是一家为临床试验提供SaaS服务的公司,为了不停改进、优化我们的产品,我们长期招募各岗位的专业老师与我们进行关于该岗位工作流程、痛点、需求等的调研研究,或产品测试。每次访谈时间一小时左右,礼金可协商,接受远程访谈。招募条件:具备该岗位1年以上全职工作经验在日常工作中使用软件工具签订产品与受访者双向保密协议允许我们在测试和面访过程当中进行录音、录屏等方式记录访谈过程   [更多]
悬赏:
悬赏
¥2500.00
载入中...
guijiang 2021-03-09 23:59 IP:贵港
悬赏:
悬赏
¥600.00
载入中...
guijiang 2021-03-10 00:02 IP:贵港
悬赏:
悬赏
¥600.00
载入中...
guijiang 2021-06-15 23:20 IP:贵港
求药品上市持有人B证质量管理规范体系文件。   [更多]
悬赏:
悬赏
¥600.00
载入中...
guijiang 2021-06-15 23:22 IP:贵港
求购配方颗粒研发方案模板,从药材到饮片到标准汤剂到配方颗粒的研发方案,工艺和质量研究等。   [更多]
悬赏:
悬赏
¥900.00
载入中...
发布需求,坐等药智客上门
  • 安全可靠,先验收再正式付款
  • 性价比超高,节省一半费用
  • 80%的需求得到了圆满解决
立即发布需求

推荐任务